XML 67 R45.htm IDEA: XBRL DOCUMENT
v3.25.4

Basic and Diluted Net Loss Per Share (Tables) | 9 Months Ended | 12 Months Ended
--- | --- | ---
Sep. 28, 2025 | Dec. 29, 2024
Basic and Diluted Net Loss Per Share [Abstract] |  |
Schedule of Basic and Diluted Net Loss Per Share | The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the thirteen and thirty-nine week periods ended September 28, 2025 and September 29, 2024 (in thousands, except share and per share amounts):
|  | Thirteen Weeks Ended |  |  | Thirty-Nine Weeks Ended |
|  | September 28, 2025 |  |  | September 29, 2024 |  |  | September 28, 2025 |  |  | September 29, 2024 |
Numerator: |  |  |  |  |  |  |  |  |  |  |  |
Net loss from continuing operations |  | $ | (15,804 | ) |  | $ | (77,958 | ) |  | $ | (30,099 | ) |  | $ | (101,433 | )
Net loss from discontinued operations |  |  | (1,100 | ) |  |  | — |  |  |  | (1,100 | ) |  |  | (2,007 | )
Net loss |  | $ | (16,904 | ) |  | $ | (77,958 | ) |  | $ | (31,199 | ) |  | $ | (103,440 | )
Denominator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Weighted average common shares outstanding, basic and diluted |  |  | 84,904,228 |  |  |  | 75,348,627 |  |  |  | 82,036,790 |  |  |  | 61,868,747 |
Net loss per share, basic and diluted: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Continuing operations |  | $ | (0.19 | ) |  | $ | (1.03 | ) |  | $ | (0.37 | ) |  | $ | (1.64 | )
Discontinued operations |  |  | (0.01 | ) |  |  | — |  |  |  | (0.01 | ) |  |  | (0.03 | )
Net loss |  | $ | (0.20 | ) |  | $ | (1.03 | ) |  | $ | (0.38 | ) |  | $ | (1.67 | )
| The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the fiscal years ended December 29, 2024 and December 31, 2023 (in thousands, except share and per share amounts):
|  | Fiscal Year Ended |
|  | December 29, |  |  | December 31, |
|  | 2024 |  |  | 2023 |
Numerator for basic loss per share: |  |  |  |  |  |
Net loss from continuing operations |  | $ | (54,444 | ) |  | $ | (96,197 | )
Net loss from discontinued operations |  |  | (2,007 | ) |  |  | (25,853 | )
Impairment loss from discontinued operations |  |  | - |  |  |  | (147,505 | )
Net loss |  |  | (56,451 | ) |  |  | (269,555 | )
Numerator for diluted loss per share |  |  |  |  |  |  |  |
Impact of 7% Notes derivative liability and interest expense, net of tax |  |  | (35,886 | ) |  |  | - |
Net loss |  | $ | (92,337 | ) |  | $ | (269,555 | )
Denominator: |  |  |  |  |  |  |  |
Weighted average shares: |  |  |  |  |  |  |  |
Denominator for basic loss per share |  |  | 66,655,837 |  |  |  | 24,723,370 |
Effect of dilutive securities: |  |  |  |  |  |  |  |
7% Notes derivative liability |  |  | 9,137,711 |  |  |  | - |
Denominator for diluted loss per share |  |  | 75,793,548 |  |  |  | 24,723,370 |
Net loss per share: |  |  |  |  |  |  |  |
Continuing operations - basic |  | $ | (0.82 | ) |  | $ | (3.89 | )
Discontinued operations - basic |  |  | (0.03 | ) |  |  | (1.05 | )
Net loss - basic |  | $ | (0.85 | ) |  | $ | (4.94 | )
Continuing operations - diluted |  | $ | (1.19 | ) |  | $ | (3.89 | )
Discontinued operations - diluted |  |  | (0.03 | ) |  |  | (1.05 | )
Net loss - diluted |  | $ | (1.22 | ) |  | $ | (4.94 | )
Schedule of Potential Common Shares Outstanding that were Excluded from the Computation of Diluted Net Loss Per Share of Common Stock | The following table presents the potential common shares outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been anti-dilutive:
|  | Thirteen Weeks Ended |  |  | Thirty-Nine Weeks Ended |
|  | September 28, 2025 |  |  | September 29, 2024 |  |  | September 28, 2025 |  |  | September 29, 2024 |
Common stock warrants |  |  | 25,670,265 |  |  |  | 31,670,265 |  |  |  | 25,670,265 |  |  |  | 31,670,265 |
Stock options and RSUs issued and outstanding |  |  | 34,256,501 |  |  |  | 14,170,385 |  |  |  | 34,256,501 |  |  |  | 14,170,385 |
Convertible notes |  |  | 77,821,528 |  |  |  | 58,579,636 |  |  |  | 77,821,528 |  |  |  | 58,579,636 |
Third SAFE Agreement |  |  | 2,750,000 |  |  |  | — |  |  |  | 2,750,000 |  |  |  | — |
Forward Purchase Agreements |  |  | 6,720,000 |  |  |  | — |  |  |  | 6,720,000 |  |  |  | — |
Deferred consideration shares |  |  | 6,666,666 |  |  |  | — |  |  |  | 6,666,666 |  |  |  | — |
Total potential common shares excluded from diluted net loss per share |  |  | 153,884,960 |  |  |  | 104,420,286 |  |  |  | 153,884,960 |  |  |  | 104,420,286 |
| The following table presents the potential common shares outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been anti-dilutive:
|  | Fiscal Year Ended |
|  | December 29, |  |  | December 31, |
|  | 2024 |  |  | 2023 |
Common stock warrants |  |  | 25,434,069 |  |  |  | 23,024,556 |
Convertible notes |  |  | 27,364,717 |  |  |  | - |
Stock options and RSUs issued and outstanding |  |  | 11,979,368 |  |  |  | 11,774,743 |
Potential common shares excluded from diluted net loss per share |  |  | 64,778,154 |  |  |  | 34,799,299 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration